Literature DB >> 11755928

Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway.

Ilan Gabriely1, Xiao Man Yang, Jane A Cases, Xiao Hui Ma, Luciano Rossetti, Nir Barzilai.   

Abstract

We examined whether acute in vivo increases in either plasma glucose or insulin concentrations stimulate PAI-1 gene expression in fat tissue. We studied chronically catheterized unstressed and awake, lean (approximately 300 g, n=12) and obese (approximately 450 g, n=12) Sprague-Dawley rats. Hyperglycemia (approximately 18mM) was induced for 3 h by glucose infusion during a pancreatic clamp (somatostatin inhibited endogenous insulin secretion). Compared with equivalent saline infusion, hyperglycemia induced a 6-7 fold increase in PAI-1 gene expression in both lean and obese rats (P<0.001). When the rate of cellular glucose uptake was matched during a euglycemic hyperinsulinemic (approximately 60 microU/ml) clamp, PAI-1 gene expression in both obese and lean rats was proportionately and significantly increased (P<0.001). We further examined whether induction of the hexosamine biosynthetic pathway would mimic the effects of hyperglycemia and hyperinsulinemia on PAI-1 gene expression. Indeed, infusion of glucosamine (GlcN, 30 micromol/kg/min), induced a approximately 3-4 fold increase (P<0.01) in PAI-1 gene expression in both lean and obese animals. While obese rats had a four times greater fat mass then the lean rats, PAI-1 gene expression remained significantly higher when expressed as per gram fat. Our results support the hypothesis that increased glucose uptake induces PAI-1 gene expression in adipose tissue, probably through the activation of the hexosamine biosynthetic pathway. These findings may account for some of the fibrinolytic alterations seen in obese type 2 diabetic humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755928     DOI: 10.1016/s0021-9150(01)00574-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

Review 1.  Surgical removal of visceral adipose tissue: effects on insulin action.

Authors:  Ilan Gabriely; Nir Barzilai
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

2.  Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets.

Authors:  N Viguerie; H Vidal; P Arner; C Holst; C Verdich; S Avizou; A Astrup; W H M Saris; I A Macdonald; E Klimcakova; K Clément; A Martinez; J Hoffstedt; T I A Sørensen; D Langin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

3.  Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile.

Authors:  Jill P Crandall; Harry Shamoon; Hillel W Cohen; Migdalia Reid; Srikanth Gajavelli; Georgeta Trandafirescu; Vafa Tabatabaie; Nir Barzilai
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958

4.  Enhanced activation of a "nutrient-sensing" pathway with age contributes to insulin resistance.

Authors:  Francine H Einstein; Sigal Fishman; Jeffery Bauman; Reid F Thompson; Derek M Huffman; Gil Atzmon; Nir Barzilai; Radhika H Muzumdar
Journal:  FASEB J       Date:  2008-06-19       Impact factor: 5.191

Review 5.  Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.

Authors:  Matteo Cesari; Marco Pahor; Raffaele Antonelli Incalzi
Journal:  Cardiovasc Ther       Date:  2010-07-07       Impact factor: 3.023

6.  Long-lived crowded-litter mice exhibit lasting effects on insulin sensitivity and energy homeostasis.

Authors:  Marianna Sadagurski; Taylor Landeryou; Manuel Blandino-Rosano; Gillian Cady; Lynda Elghazi; Daniel Meister; Lauren See; Andrzej Bartke; Ernesto Bernal-Mizrachi; Richard A Miller
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

7.  Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Authors:  Monica M Dua; Noriyuki Miyama; Junya Azuma; Geoffrey M Schultz; Mien Sho; John Morser; Ronald L Dalman
Journal:  Surgery       Date:  2010-06-19       Impact factor: 3.982

8.  Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications.

Authors:  Assunta Pandolfi; Elena Anna De Filippis
Journal:  Genes Nutr       Date:  2007-10-17       Impact factor: 5.523

Review 9.  Vascular endothelium dysfunction: a conservative target in metabolic disorders.

Authors:  Shalini Jamwal; Saurabh Sharma
Journal:  Inflamm Res       Date:  2018-01-25       Impact factor: 4.575

Review 10.  Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity.

Authors:  P Newsholme; E P Haber; S M Hirabara; E L O Rebelato; J Procopio; D Morgan; H C Oliveira-Emilio; A R Carpinelli; R Curi
Journal:  J Physiol       Date:  2007-06-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.